DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Seizalam is a drug marketed by Meridian Medcl Techn and is included in one NDA.
The generic ingredient in SEIZALAM is midazolam hydrochloride. There are nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the midazolam hydrochloride profile page.
A generic version of SEIZALAM was approved as midazolam hydrochloride by FRESENIUS KABI USA on June 20th, 2000.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Meridian Medcl Techn||SEIZALAM||midazolam hydrochloride||SOLUTION;INTRAMUSCULAR||209566-001||Sep 14, 2018||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|